What are the possible causes and treatments for blurred vision at night, especially in older adults or those with a history of eye diseases, diabetes, or other conditions that could affect vision?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Blurred Vision at Night: Causes and Management

Blurred vision at night in adults, particularly those with diabetes or pre-existing eye disease, requires urgent ophthalmologic evaluation to rule out diabetic retinopathy, cataracts, or other sight-threatening conditions that may be asymptomatic despite progressive disease.

Primary Differential Diagnosis

Diabetic-Related Causes

  • Diabetic retinopathy is the most frequent cause of new blindness in adults aged 20-74 years and can present with blurred vision, including night vision disturbances 1
  • Acute hyperglycemia can cause blurred vision as the first and only presenting symptom of uncontrolled diabetes, even before classic diabetic symptoms appear 2
  • Diabetic keratopathy with acute corneal edema can cause sudden vision changes when blood sugar is poorly controlled 3
  • Cataracts occur earlier and more frequently in diabetic patients and are a major cause of visual impairment, responsible for vision loss in 33% of older-onset diabetic patients 4, 5

Non-Diabetic Causes in Older Adults

  • Age-related cataracts are 1.5 times more likely in elderly diabetic persons compared to age-matched non-diabetic persons 4
  • Glaucoma occurs earlier and more frequently in people with diabetes 1
  • Dry eye syndrome and other comorbid ocular conditions contribute to vision loss synergistically with diabetes 4

Immediate Action Required

Prompt referral to an ophthalmologist is mandatory for any patient with diabetes presenting with vision changes, as sight-threatening disease may be asymptomatic and delayed treatment significantly worsens outcomes 6, 1.

Specific Referral Criteria

  • Any level of macular edema 1, 6
  • Severe nonproliferative diabetic retinopathy (NPDR) 1, 6
  • Any proliferative diabetic retinopathy (PDR) 1, 6
  • Visual symptoms in diabetic patients regardless of known retinopathy status 6

Screening Recommendations

For Type 2 Diabetes (Most Relevant for Older Adults)

  • Initial dilated comprehensive eye examination by ophthalmologist or optometrist should occur at the time of diabetes diagnosis 1, 7
  • Annual follow-up examinations are required if any level of retinopathy is present 1
  • Screening every 1-2 years may be considered only if there is no evidence of retinopathy for one or more annual exams AND glycemia is well controlled 1, 7

For Type 1 Diabetes

  • Initial examination within 5 years after diabetes onset 1, 7
  • Annual examinations thereafter 1

Risk Factor Optimization (Grade A Recommendations)

Glycemic Control

  • Target hemoglobin A1c <7% to prevent and delay diabetic retinopathy progression 7, 6
  • Intensive glycemic control prevents retinopathy in 29-37% of patients compared to standard care 6
  • Check glycosylated hemoglobin immediately in patients presenting with blurred vision to identify uncontrolled diabetes 2

Blood Pressure Control

  • Target blood pressure <130/80 mmHg to reduce retinopathy risk and progression 7, 6
  • Hypertension significantly increases risk of macular hemorrhage and must be aggressively controlled 6
  • Blood pressure optimization is a Grade A recommendation for preventing diabetic retinopathy 7

Lipid Control

  • Target LDL <100 mg/dL for high cardiovascular risk patients 7
  • Optimizing serum lipid control is a Grade A recommendation for reducing retinopathy risk 7, 1

Treatment Considerations

For Confirmed Diabetic Retinopathy

  • Intravitreal anti-VEGF injections (ranibizumab or aflibercept) are first-line treatment for diabetic macular edema, administered monthly initially 6
  • Laser photocoagulation remains indicated for high-risk PDR and clinically significant macular edema 1, 6
  • Anti-VEGF therapy improves retinopathy severity scores by 2+ steps in 29-37% of patients versus 8-16% with laser alone 6

Cardiovascular Protection

  • Aspirin therapy for cardioprotection should NOT be discontinued, as it does not increase retinal hemorrhage risk in diabetic retinopathy patients 1, 7, 6
  • Aspirin is indicated for cardiovascular protection in diabetic patients with 10-year CV risk >10% 7

Critical Clinical Pitfalls

  • Do not delay referral until symptoms worsen - patients with sight-threatening disease may be completely asymptomatic 6, 1
  • Do not assume vision changes are benign refractive errors - blurred vision may be the only presenting symptom of uncontrolled diabetes before classic symptoms appear 2
  • Do not overlook systemic disease - sudden corneal opacity without obvious trauma should prompt evaluation for poorly controlled diabetes 3
  • Do not wait for annual screening - any new visual symptoms in diabetic patients require immediate ophthalmologic evaluation 6

Special Population: Pregnancy

  • Pregnant diabetic patients require eye examination in the first trimester with close follow-up throughout pregnancy and for 1 year postpartum, as pregnancy accelerates retinopathy progression 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Eye disease and the older diabetic.

Clinics in geriatric medicine, 2008

Research

Visual impairment in diabetes.

Ophthalmology, 1984

Guideline

Management of Macular Hemorrhage in Diabetic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Preventing Diabetic Retinopathy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.